Advertisement

Oral Manifestations of Immunodeficiencies and Transplantation Medicine

      Patients who have received a stem cell or solid transplant are acutely and often chronically immunosuppressed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      References

        • Sonis S.T.
        Pathobiology of oral mucositis: novel insights and opportunities.
        J Support Oncol. 2007; 5: 3-11
        • Villa A.
        • Sonis S.T.
        Mucositis: pathobiology and management.
        Curr Opin Oncol. 2015; 27: 159-164
        • Lerman M.A.
        • Laudenbach J.
        • Marty F.M.
        • et al.
        Management of oral infections in cancer patients.
        Dent Clin North Am. 2008; 52 (ix): 129-153
        • Palmason S.
        • Marty F.M.
        • Treister N.S.
        How do we manage oral infections in allogeneic stem cell transplantation and other severely immunocompromised patients?.
        Oral Maxillofac Surg Clin North Am. 2011; 23 (vii): 579-599
        • Cho H.
        • Lee K.H.
        • Colquhoun A.N.
        • et al.
        Invasive oral aspergillosis in a patient with acute myeloid leukaemia.
        Aust Dent J. 2010; 55: 214-218
        • Marques S.A.
        Fungal infections of the mucous membrane.
        Dermatol Ther. 2010; 23: 243-250
        • Tejani S.
        • Sultan A.
        • Stojanov I.
        • et al.
        Candidal carriage predicts candidiasis during topical immunosuppressive therapy: a preliminary retrospective cohort study.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122: 448-454
        • Curtis R.E.
        • Metayer C.
        • Rizzo J.D.
        • et al.
        Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.
        Blood. 2005; 105: 3802-3811
        • Engels E.A.
        • Pfeiffer R.M.
        • Fraumeni Jr., J.F.
        • et al.
        Spectrum of cancer risk among US solid organ transplant recipients.
        JAMA. 2011; 306: 1891-1901
        • Socie G.
        • Rizzo J.D.
        Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation.
        Semin Hematol. 2012; 49: 4-9
        • Mawardi H.
        • Elad S.
        • Correa M.E.
        • et al.
        Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.
        Bone Marrow Transplant. 2011; 46: 884-891
        • Rizzo J.D.
        • Curtis R.E.
        • Socie G.
        • et al.
        Solid cancers after allogeneic hematopoietic cell transplantation.
        Blood. 2009; 113: 1175-1183
        • Ion D.
        • Stevenson K.
        • Woo S.B.
        • et al.
        Characterization of oral involvement in acute graft-versus-host disease.
        Biol Blood Marrow Transplant. 2014; 20: 1717-1721
        • Kuten-Shorrer M.
        • Woo S.B.
        • Treister N.S.
        Oral graft-versus-host disease.
        Dent Clin North Am. 2014; 58: 351-368
        • Woo S.B.
        Oral pathology: a comprehensive atlas and text.
        Saunders Elsevier, Philadelphia2012
        • Hasturk H.
        • Tezcan I.
        • Yel L.
        • et al.
        A case of chronic severe neutropenia: oral findings and consequences of short-term granulocyte colony-stimulating factor treatment.
        Aust Dent J. 1998; 43: 9-13
        • Raber-Durlacher J.E.
        • Elad S.
        • Barasch A.
        Oral mucositis.
        Oral Oncol. 2010; 46: 452-456
        • Reznik D.A.
        Oral manifestations of HIV disease.
        Top HIV Med. 2005; 13: 143-148
        • Petti S.
        • Polimeni A.
        • Berloco P.B.
        • et al.
        Orofacial diseases in solid organ and hematopoietic stem cell transplant recipients.
        Oral Dis. 2013; 19: 18-36
        • Martins F.
        • de Oliveira M.A.
        • Wang Q.
        • et al.
        A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients.
        Oral Oncol. 2013; 49: 293-298
        • Sonis S.
        • Treister N.
        • Chawla S.
        • et al.
        Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients.
        Cancer. 2010; 116: 210-215
        • Yuan A.
        • Kurtz S.L.
        • Barysauskas C.M.
        • et al.
        Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors.
        Oral Oncol. 2015; 51: 1026-1033